Seventy insulin-using patients were recruited from eight centres in Brisbane, Sydney, Melbourne, Adelaide and Perth, Australia; 51% had type 1 diabetes and 49% type 2 diabetes. Demo-graphic details ...
At entry to the study 43 patients (61%) were using Novopen ® 3 to administer their insulin, 22 (31%) were using syringes, and five (7%) had used a combination of Novopen ® 3 and syringes. 43 (90%) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results